Golnaz Baghdadi, Bioelectric PhD student at Biomedical Engineering Department of Amirkabir University of Technology (AUT), told Mehr News that the tDCS device has been developed in Iran for the first time by a team at AUT led by Dr. Farzad Tohidkhah, rector of the Biomedical Engineering Department.
“The brain stimulator tDCS device is used in treatment of depression, on people suffering from attention deficit disorder or patients with Parkinson’s Disease,” she said.
Explaining about the device performance, she said “the device stimulates the brain by delivering a constant, low current to the brain area of interest via electrodes on the scalp. After a few sessions, the patient will start showing signs of improvement.”
She went on to add, “the effects will last up to three to four months, and then the patient needs to go back to the clinic so that the device will be set on a specific dosage to be used by the patient at home.”
“Compared to the foreign version, the Iranian tDCS device is programmable by computer, can store data via a flash drive, has a touch screen for ease of use, and is more affordable,” she said.
Baghdadi maintained that the device is currently at the commercialization stage, adding “tests conducted on the device have yielded positive results and it is now ready to receive orders.”
MS/3851603